Genomic sequence of chorioallantois vaccinia virus Ankara, the ancestor of modified vaccinia virus Ankara
Meisinger-Henschel C, Schmidt M, Lukassen S, Linke B, Krause L, Konietzny S, Goesmann A, Howley P, Chaplin P, Suter M, Hausmann J (2007)
JOURNAL OF GENERAL VIROLOGY 88(12): 3249-3259.
Download
No fulltext has been uploaded. References only!
Journal Article
| Original Article
| Published
| English
No fulltext has been uploaded
Author
Meisinger-Henschel, Christine
;
Schmidt, Michaela
;
Lukassen, Susanne
;
Linke, BurkhardUniBi
;
Krause, Lutz
;
Konietzny, Sebastian
;
Goesmann, AlexanderUniBi
;
Howley, Paul
;
Chaplin, Paul
;
Suter, Mark
;
Hausmann, Juergen

Department
Centrum für Biotechnologie
Centrum für Biotechnologie > Research Group A. Goesmann
Centrum für Biotechnologie > Technologieplattformen > Bioinformatics Resource Facility
Technische Fakultät > Computational Genomics
Technische Fakultät > AG Genominformatik
Centrum für Biotechnologie > Institut für Bioinformatik
Centrum für Biotechnologie > Research Group A. Goesmann
Centrum für Biotechnologie > Technologieplattformen > Bioinformatics Resource Facility
Technische Fakultät > Computational Genomics
Technische Fakultät > AG Genominformatik
Centrum für Biotechnologie > Institut für Bioinformatik
Publishing Year
ISSN
eISSN
PUB-ID
Cite this
Meisinger-Henschel C, Schmidt M, Lukassen S, et al. Genomic sequence of chorioallantois vaccinia virus Ankara, the ancestor of modified vaccinia virus Ankara. JOURNAL OF GENERAL VIROLOGY. 2007;88(12):3249-3259.
Meisinger-Henschel, C., Schmidt, M., Lukassen, S., Linke, B., Krause, L., Konietzny, S., Goesmann, A., et al. (2007). Genomic sequence of chorioallantois vaccinia virus Ankara, the ancestor of modified vaccinia virus Ankara. JOURNAL OF GENERAL VIROLOGY, 88(12), 3249-3259. doi:10.1099/vir.0.83156-0
Meisinger-Henschel, C., Schmidt, M., Lukassen, S., Linke, B., Krause, L., Konietzny, S., Goesmann, A., Howley, P., Chaplin, P., Suter, M., et al. (2007). Genomic sequence of chorioallantois vaccinia virus Ankara, the ancestor of modified vaccinia virus Ankara. JOURNAL OF GENERAL VIROLOGY 88, 3249-3259.
Meisinger-Henschel, C., et al., 2007. Genomic sequence of chorioallantois vaccinia virus Ankara, the ancestor of modified vaccinia virus Ankara. JOURNAL OF GENERAL VIROLOGY, 88(12), p 3249-3259.
C. Meisinger-Henschel, et al., “Genomic sequence of chorioallantois vaccinia virus Ankara, the ancestor of modified vaccinia virus Ankara”, JOURNAL OF GENERAL VIROLOGY, vol. 88, 2007, pp. 3249-3259.
Meisinger-Henschel, C., Schmidt, M., Lukassen, S., Linke, B., Krause, L., Konietzny, S., Goesmann, A., Howley, P., Chaplin, P., Suter, M., Hausmann, J.: Genomic sequence of chorioallantois vaccinia virus Ankara, the ancestor of modified vaccinia virus Ankara. JOURNAL OF GENERAL VIROLOGY. 88, 3249-3259 (2007).
Meisinger-Henschel, Christine, Schmidt, Michaela, Lukassen, Susanne, Linke, Burkhard, Krause, Lutz, Konietzny, Sebastian, Goesmann, Alexander, Howley, Paul, Chaplin, Paul, Suter, Mark, and Hausmann, Juergen. “Genomic sequence of chorioallantois vaccinia virus Ankara, the ancestor of modified vaccinia virus Ankara”. JOURNAL OF GENERAL VIROLOGY 88.12 (2007): 3249-3259.
This data publication is cited in the following publications:
This publication cites the following data publications:
Data provided by the European Bioinformatics Institute (EBI)
UNIPROT
213 Items found citing this article of which 10 are displayed
Core protein required for morphogenesis (UNIPROT: A9J0Q2)
Organism: Vaccinia virus (strain Ankara)
Download in FASTA format
Organism: Vaccinia virus (strain Ankara)
Download in FASTA format
Intermediate transcription factor 3 (VITF-3) small subunit (UNIPROT: A9J0Q7)
Organism: Vaccinia virus (strain Ankara)
Download in FASTA format
Organism: Vaccinia virus (strain Ankara)
Download in FASTA format
Ribonucleotide reductase small subunit (UNIPROT: A9J1I4)
Organism: Vaccinia virus (strain Ankara)
Download in FASTA format
Organism: Vaccinia virus (strain Ankara)
Download in FASTA format
11K DNA-binding phosphoprotein (UNIPROT: A9J1K1)
Organism: Vaccinia virus (strain Ankara)
Download in FASTA format
Organism: Vaccinia virus (strain Ankara)
Download in FASTA format
Putative uncharacterized protein CVA064 (UNIPROT: A9J1K3)
Organism: Vaccinia virus (strain Ankara)
Download in FASTA format
Organism: Vaccinia virus (strain Ankara)
Download in FASTA format
Soluble myristylprotein (UNIPROT: A9J1K8)
Organism: Vaccinia virus (strain Ankara)
Download in FASTA format
Organism: Vaccinia virus (strain Ankara)
Download in FASTA format
DNA topoisomerase IB (UNIPROT: A9J1S7)
Organism: Vaccinia virus (strain Ankara)
Download in FASTA format
Organism: Vaccinia virus (strain Ankara)
Download in FASTA format
Large subunit of mRNA capping enzyme (UNIPROT: A9J1T1)
Organism: Vaccinia virus (strain Ankara)
Download in FASTA format
Organism: Vaccinia virus (strain Ankara)
Download in FASTA format
Uracil-DNA glycosylase (UNIPROT: A9J1T7)
Organism: Vaccinia virus (strain Ankara)
Download in FASTA format
Organism: Vaccinia virus (strain Ankara)
Download in FASTA format
IMV entry-fusion complex membrane protein (UNIPROT: A9J0T9)
Organism: Vaccinia virus (strain Ankara)
Download in FASTA format
Organism: Vaccinia virus (strain Ankara)
Download in FASTA format
EMBL
1 Item found citing this article
40 Citations in Europe PMC
Data provided by Europe PubMed Central.
Characterization of indels in poxvirus genomes.
Coulson D, Upton C., Virus Genes 42(2), 2011
PMID: 21153876
Coulson D, Upton C., Virus Genes 42(2), 2011
PMID: 21153876
Deletion of the A35 gene from Modified Vaccinia Virus Ankara increases immunogenicity and isotype switching.
Rehm KE, Roper RL., Vaccine 29(17), 2011
PMID: 21352940
Rehm KE, Roper RL., Vaccine 29(17), 2011
PMID: 21352940
Deletion of major nonessential genomic regions in the vaccinia virus Lister strain enhances attenuation without altering vaccine efficacy in mice.
Dimier J, Ferrier-Rembert A, Pradeau-Aubreton K, Hebben M, Spehner D, Favier AL, Gratier D, Garin D, Crance JM, Drillien R., J Virol 85(10), 2011
PMID: 21367889
Dimier J, Ferrier-Rembert A, Pradeau-Aubreton K, Hebben M, Spehner D, Favier AL, Gratier D, Garin D, Crance JM, Drillien R., J Virol 85(10), 2011
PMID: 21367889
The strategic use of novel smallpox vaccines in the post-eradication world.
Golden JW, Hooper JW., Expert Rev Vaccines 10(7), 2011
PMID: 21806397
Golden JW, Hooper JW., Expert Rev Vaccines 10(7), 2011
PMID: 21806397
Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors.
Walsh SR, Dolin R., Expert Rev Vaccines 10(8), 2011
PMID: 21854314
Walsh SR, Dolin R., Expert Rev Vaccines 10(8), 2011
PMID: 21854314
Innate immune recognition of poxviral vaccine vectors.
Lousberg EL, Diener KR, Brown MP, Hayball JD., Expert Rev Vaccines 10(10), 2011
PMID: 21988308
Lousberg EL, Diener KR, Brown MP, Hayball JD., Expert Rev Vaccines 10(10), 2011
PMID: 21988308
A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE.
von Krempelhuber A, Vollmar J, Pokorny R, Rapp P, Wulff N, Petzold B, Handley A, Mateo L, Siersbol H, Kollaritsch H, Chaplin P., Vaccine 28(5), 2010
PMID: 19944151
von Krempelhuber A, Vollmar J, Pokorny R, Rapp P, Wulff N, Petzold B, Handley A, Mateo L, Siersbol H, Kollaritsch H, Chaplin P., Vaccine 28(5), 2010
PMID: 19944151
Mutations in modified virus Ankara protein 183 render it a non-functional counterpart of B14, an inhibitor of nuclear factor kappaB activation.
McCoy LE, Fahy AS, Chen RA, Smith GL., J Gen Virol 91(pt 9), 2010
PMID: 20444990
McCoy LE, Fahy AS, Chen RA, Smith GL., J Gen Virol 91(pt 9), 2010
PMID: 20444990
Introduction of the six major genomic deletions of modified vaccinia virus Ankara (MVA) into the parental vaccinia virus is not sufficient to reproduce an MVA-like phenotype in cell culture and in mice.
Meisinger-Henschel C, Späth M, Lukassen S, Wolferstätter M, Kachelriess H, Baur K, Dirmeier U, Wagner M, Chaplin P, Suter M, Hausmann J., J Virol 84(19), 2010
PMID: 20668072
Meisinger-Henschel C, Späth M, Lukassen S, Wolferstätter M, Kachelriess H, Baur K, Dirmeier U, Wagner M, Chaplin P, Suter M, Hausmann J., J Virol 84(19), 2010
PMID: 20668072
Interaction of orthopoxviruses with the cellular ubiquitin-ligase system.
Shchelkunov SN., Virus Genes 41(3), 2010
PMID: 20703935
Shchelkunov SN., Virus Genes 41(3), 2010
PMID: 20703935
Genome comparison of a nonpathogenic myxoma virus field strain with its ancestor, the virulent Lausanne strain.
Morales M, Ramírez MA, Cano MJ, Párraga M, Castilla J, Pérez-Ordoyo LI, Torres JM, Bárcena J., J Virol 83(5), 2009
PMID: 19091868
Morales M, Ramírez MA, Cano MJ, Párraga M, Castilla J, Pérez-Ordoyo LI, Torres JM, Bárcena J., J Virol 83(5), 2009
PMID: 19091868
Recombinant Modified Vaccinia Ankara (MVA) effectively boosts DNA-primed HIV-specific immune responses in humans despite pre-existing vaccinia immunity.
Gudmundsdotter L, Nilsson C, Brave A, Hejdeman B, Earl P, Moss B, Robb M, Cox J, Michael N, Marovich M, Biberfeld G, Sandström E, Wahren B., Vaccine 27(33), 2009
PMID: 19450644
Gudmundsdotter L, Nilsson C, Brave A, Hejdeman B, Earl P, Moss B, Robb M, Cox J, Michael N, Marovich M, Biberfeld G, Sandström E, Wahren B., Vaccine 27(33), 2009
PMID: 19450644
Modified vaccinia Ankara strains with identical coding sequences actually represent complex mixtures of viruses that determine the biological properties of each strain.
Suter M, Meisinger-Henschel C, Tzatzaris M, Hülsemann V, Lukassen S, Wulff NH, Hausmann J, Howley P, Chaplin P., Vaccine 27(52), 2009
PMID: 19539582
Suter M, Meisinger-Henschel C, Tzatzaris M, Hülsemann V, Lukassen S, Wulff NH, Hausmann J, Howley P, Chaplin P., Vaccine 27(52), 2009
PMID: 19539582
Evaluation of the efficacy of modified vaccinia Ankara (MVA)/IMVAMUNE against aerosolized rabbitpox virus in a rabbit model.
Garza NL, Hatkin JM, Livingston V, Nichols DK, Chaplin PJ, Volkmann A, Fisher D, Nalca A., Vaccine 27(40), 2009
PMID: 19632316
Garza NL, Hatkin JM, Livingston V, Nichols DK, Chaplin PJ, Volkmann A, Fisher D, Nalca A., Vaccine 27(40), 2009
PMID: 19632316
Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection.
Samuelsson C, Hausmann J, Lauterbach H, Schmidt M, Akira S, Wagner H, Chaplin P, Suter M, O'Keeffe M, Hochrein H., J Clin Invest 118(5), 2008
PMID: 18398511
Samuelsson C, Hausmann J, Lauterbach H, Schmidt M, Akira S, Wagner H, Chaplin P, Suter M, O'Keeffe M, Hochrein H., J Clin Invest 118(5), 2008
PMID: 18398511
Export
0 Marked PublicationsWeb of Science
View record in Web of Science®Sources
PMID: 18024893
PubMed | Europe PMC